• Channels
    • All News
    • In Focus
    • Special
    • AI
    • Bioregnum
    • Biotech Voices
    • Cell/Gene Tx
    • China
    • Coronavirus
    • Deals
    • Diagnostics
    • Discovery
    • FDA+
    • Financing
    • Health Tech
    • Law
    • Letters to the Editor
    • Manufacturing
    • Marketing
    • Nikkei Biotechnology
    • Opinion
    • Outsourcing
    • Peer Review
    • People
    • Pharma
    • R&D
    • Startups
    • Weekly
  • Webinars
  • Biopharma Jobs
  • More
    • Work at Endpoints
    • Letter to Editors
    • Editorial Standards
    • IPO Tracker
    • Webinars
    • Events
    • Sponsored Posts
    • Advertise
    • Privacy Policy
    • Endpoints Merch
    • About Us
    • Help
  • SIGN UP
  • LOG IN

Re­sis­tance mu­ta­tions found in those re­ceiv­ing GSK and Vir’s mon­o­clon­al for Delta, new re­search shows

4 years ago
Coronavirus

SEC sin­gles out Zai Lab, BeiGene, Hutchmed for reg­u­la­to­ry scruti­ny — with threats of delist­ing

4 years ago
China
FDA+

Whistle­blow­er com­plaint al­leges more bul­ly­ing, ethics vi­o­la­tions un­der Lan­der's lead­er­ship — re­port

4 years ago
People

Or­p­hazyme ad­mits this may be the end, as it asks court to over­see re­struc­tur­ing

4 years ago
Pharma

Centes­sa gives An­toine Yver a new role, brings his old col­league on board; Pre­lude to a change: Jane Huang sets up ...

4 years ago
Peer Review

FDA lifts a clin­i­cal hold on Se­lec­ta gene ther­a­py af­ter an­oth­er de­lay ham­pers R&D plans

4 years ago
R&D
FDA+

Big Phar­ma part­ners join ini­tia­tive to dri­ve eq­ui­ty and in­clu­sion in dig­i­tal tri­als

4 years ago
Pharma

Fed­er­al bank­rupt­cy judge ap­proves Pur­due Phar­ma and Sack­ler­s' $6 bil­lion opi­oid set­tle­ment

4 years ago
Pharma
Law

Up­dat­ed: Three big Con­gres­sion­al hear­ings next week to set the tenor on ac­cel­er­at­ed ap­provals, pan­demics, drug ...

4 years ago
Pharma
FDA+

Mor­phoSys sends its Con­stel­la­tion drug work to Ger­many, shut­ter­ing US R&D and tak­ing a $250M hit in re­or­ga­ni­za­tion

4 years ago
Deals
R&D

Lon­za com­pletes Chi­na ex­pan­sion to sup­port HPA­PI pro­duc­tion

4 years ago
Pharma
Manufacturing

KE­LIX ac­quires Mo­roc­can man­u­fac­tur­er; Sus­tain­abil­i­ty and char­i­ty fo­cus of Catal­en­t's cor­po­rate re­spon­si­bil­i­ty re­port

4 years ago
Pharma
Manufacturing

Q&A: Fran­co Ste­van­to leads fam­i­ly busi­ness through pan­dem­ic, IPO and on­to the glob­al stage

4 years ago
People
Manufacturing

Trust in health­care? Not so healthy af­ter the pan­dem­ic, Edel­man’s lat­est sur­vey finds

4 years ago
Pharma
Marketing

An­oth­er biotech is feel­ing the heat as it un­der­goes 're­or­ga­ni­za­tion' with plans to lay off about 100

4 years ago
People
Diagnostics

Not an an­ti-ag­ing play? Al­tos’ top sci­en­tist says they can pre­vent ag­ing in 20 years

4 years ago
Startups
R&D

CSL and Gri­fols sue US bor­der pa­trol for block­ing Mex­i­can plas­ma do­na­tions

4 years ago
Cell/Gene Tx
Manufacturing

Look­ing to bat­tle ri­vals in a big mar­ket, Ab­b­Vie is head­ed to the FDA af­ter clear­ing a PhI­II hur­dle for chron­ic ...

4 years ago
R&D

J&J ex­pands deal with lit­tle-known Welsh biotech us­ing 3D print­ing to bet­ter en­cap­su­late drugs

4 years ago
Deals

Mod­er­na plays Big Phar­ma ball with CEO pay, push­ing bil­lion­aire Ban­cel in­to the ma­jor leagues

4 years ago
People
R&D

The of­fer does­n't stop at Covid. No­var­tis opens up man­u­fac­tur­ing ops to make Caris­ma’s CAR-M cell ther­a­py

4 years ago
Pharma
Cell/Gene Tx

Covid-19 as a po­lit­i­cal foot­ball: Gov­ern­ment fund­ing for more vac­cine, treat­ment sup­plies stalls

4 years ago
Coronavirus

Aim­ing to drug ge­net­ic mod­i­fiers, Roche-part­nered biotech bags $31M to fu­el a dri­ve to­ward clin­ic

4 years ago
Financing

Morn­ing­side re­veals its lat­est biotech ef­fort, seek­ing to tack­le wide range of in­flam­ma­to­ry dis­eases

4 years ago
Financing
Startups
First page Previous page 560561562563564565566 Next page Last page
Endpoints News

Bioscience & Technology Business Center
The University of Kansas
Lawrence, Kansas

Latest

  • All News
  • Special
  • In Focus

Channels

  • AI
  • Bioregnum
  • Biotech Voices
  • Cell/Gene Tx
  • China
  • Coronavirus
  • Deals
  • Diagnostics
  • Discovery
  • FDA+
  • Financing
  • Health Tech
  • Law
  • Letters to the Editor
  • Manufacturing
  • Marketing
  • Nikkei Biotechnology
  • Opinion
  • Outsourcing
  • Peer Review
  • People
  • Pharma
  • R&D
  • Startups
  • Weekly

More

  • Work at Endpoints
  • Letter to Editors
  • Editorial Standards
  • IPO Tracker
  • Events
  • Webinars
  • Sponsored Posts
  • Advertise
  • Endpoints Merch
  • About Us
  • Help

Work in biotech

  • Endpoints Careers

© Endpoints News 2025

  • Help
  • Advertise
  • Privacy Policy
  • Business Model
FT Specialist Logo
A service from the Financial Times